Drug Trial Radar · NCT00615433
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Last checked: Nov 19, 2026Latest source record: Jun 12, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
478
Actual
Start
Jan 2008
Primary completion
Dec 2009
Study completion Jan 2010
Sponsor
- Lead sponsor
- Sumitomo Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 14, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo.
Conditions
- Schizophrenia
Interventions
LurasidoneDrug
120mg/day
OlanzapineDrug
15mg/day
Placebo comparatorDrug
Placebor Comparator
Lurasidone 40 mg tabletsDrug
Lurasidone 40 mg tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Total PANSS (Positive and Negative Syndrome Scale)Score From Baseline to the End of the Double Blind Treatment Period.Time frame: Baseline and 6 weeks
Locations
52 sites in 5 countries. Site status is shown where the registry gives one.
K&S Professional Research Services LLC
Little Rock, Arkansas
Woodland International Research Group, LLC
Little Rock, Arkansas
Clinical Pharmacological Studies, Inc.
Cerritos, California
Excell Research
Oceanside, California
University of California at Irvine Medical Center
Orange, California
California Clinical Trials
Paramount, California
CNRI - San Diego, LLC
San Diego, California
UCSD Medical Center
San Diego, California
Collaborative Neuroscience Network Inc.
Torrance, California
Florida Clinical Research Center, LLC
Fruitland Park, Florida
Segal Institute for Clinical Research
North Miami, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
Uptown Research Institute, LLC
Chicago, Illinois
Alexian Brothers Health System
Hoffman Estates, Illinois
Lousiana Clinical Research, LLC
Shreveport, Louisiana
Precise Research Center
Flowood, Mississippi
St. Charles Psychiatric Associates-Midwest Research
Saint Charles, Missouri
St. Louis Clinical Trials
St Louis, Missouri
CRI Worldwide @ Lourdes
Willingboro, New Jersey
Neurobehavioral Research Inc.
Cedarhurst, New York
University of North Carolina at Chapel Hill
Raleigh, North Carolina
Keystone Clinical Studies, LLC
Norristown, Pennsylvania
Vanderbilt Heart and Vascular Institute
Nashville, Tennessee
Community Clinical Research, Inc.
Austin, Texas
Claghorn-Lesem Research Clinic, Inc.
Houston, Texas
CIPNA Centro de Investigaciones y Proyectos en Neurociencias
Barranquilla, Colombia
Centro de Investigacion y Atencion para la Salud Mental
Bogotá, Colombia
Centro de Investigaciones del Sistema Nervioso Limitada
Bogotá, Colombia
Psynapsis Salud Mental, S.A.
Risaralda, Colombia
Instituto Colombiano del Sistema Nervioso Clinica Montserrat
Cundinamarca, Bogota D.C., Colombia
Vijayawada Institute of Mental Health and Neurosciences
Vijaywada, Andh Prad, India
Government Hospital for Mental Care
Visakhapatnam, Andh Prad, India
Hospital for Mental Health - Dept of Psychiatry
Ahmedabad, Gujarat, India
Sheth Vadilal Sarabhai General Hospital
Ahmedabad, Gujarat, India
SBKS Medical College and Brij Psychiatry Hospital
Vadodara, Gujarat, India
Victoria Hospital
Bangalore, Karna, India
Kasturba Medical College
Mangalore, Karna, India
Father Muller Institute of Medical Education and Research
Mangalore, Karna, India
Justice K.S. Hedge Charitable Hospital
Mangalore, Karna, India
Kasturba Hospital
Manipal, Karna, India
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.